2017
DOI: 10.21037/qims.2017.02.09
|View full text |Cite|
|
Sign up to set email alerts
|

A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging

Abstract: This paper aims to update the clinical researches using superparamagnetic iron oxide (SPIO) nanoparticles as magnetic resonance imaging (MRI) contrast agent published during the past five years.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
123
0
2

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 199 publications
(125 citation statements)
references
References 164 publications
0
123
0
2
Order By: Relevance
“…Magnetic nanoparticles are already versatilely used in research and partly in clinical issues for hyperthermia or drug delivery in tumor [31][32][33][34][35] and infection treatment [36,37], as contrast agents for magnetic resonance imaging [38][39][40], and others [41,42]. The biocompatibility of certain magnetic nanoparticles with different composition, magnetic properties or size has already been published [43,44].…”
Section: Introductionmentioning
confidence: 99%
“…Magnetic nanoparticles are already versatilely used in research and partly in clinical issues for hyperthermia or drug delivery in tumor [31][32][33][34][35] and infection treatment [36,37], as contrast agents for magnetic resonance imaging [38][39][40], and others [41,42]. The biocompatibility of certain magnetic nanoparticles with different composition, magnetic properties or size has already been published [43,44].…”
Section: Introductionmentioning
confidence: 99%
“…In order to improve the symptoms by drug therapy based on the diagnosis at the early stage of the disease, MRI CAs, especially SPIO and USPIO, have already been developed in imaging and targeting drug delivery. Despite the fact that regulatory bodies have already approved some SPIO agents for many years, the clinical application of these agents has been proven a difficult journey (Wáng and Idée, 2017). For instance, by the end of 2015, only five types of SPIO had been designed and applied in clinical settings as magnetic resonance CAs (Yang et al, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…Mater. [74] LN detection with SPION results in an improved accurate diagnosis of LN metastases both preoperatively and intraoperatively, which may become a cost-effective strategy for clinic applications. [62,63] Many clinical trials have shown favorable results of intraoperative SLN detection with ICG, [64][65][66] even in robotassisted laparoscopic surgery.…”
Section: Mapping Sentinel Lymph Nodes (Slns) For Surgerymentioning
confidence: 99%
“…[58,72,73] The benefits of SPION for LN detection include their availability by both intravenous and interstitial administrations, which facilitate preoperative biopsy with magnetic resonance imaging (MRI) and intraoperative SLN dissection guidance for further histopathological evaluations with a simple hand-hold probe. [74] LN detection with SPION results in an improved accurate diagnosis of LN metastases both preoperatively and intraoperatively, which may become a cost-effective strategy for clinic applications. [75][76][77] These benefits of SPION can also be the potential benefits of other NMs for IGS-based LN detection.…”
Section: Mapping Sentinel Lymph Nodes (Slns) For Surgerymentioning
confidence: 99%